PMID- 11996972 OWN - NLM STAT- MEDLINE DCOM- 20020710 LR - 20190702 IS - 0027-5107 (Print) IS - 0027-5107 (Linking) VI - 502 IP - 1-2 DP - 2002 May 22 TI - Use of yeast transformation by oligonucleotides to study DNA lesion bypass in vivo. PG - 53-60 AB - We have studied mutagenic specificities of DNA lesions in vivo in yeast CYC1 oligonucleotide transformation assay. We introduced two lesions into oligonucleotides. One was a nucleoside analog, 3,4-dihydro-6H,8H-pyrimido[4,5-c][1,2]oxazin-7-one 2'-deoxyriboside (dP), which is highly mutagenic to bacteria. It is supposed to be a miscoding, but otherwise good template for DNA polymerases. The other lesion was the TT pyrimidine(6-4)pyrimidone photoproduct, one of the typical UV lesions, which blocks DNA replication. These oligonucleotides were used to transform yeast cyc1 mutants with ochre nonsense mutation to Cyc1+. As expected from its templating properties in vitro, the transforming activity of dP-containing oligonucleotides was similar to those of unmodified oligonucleotides. Results indicated that dP may direct incorporation of guanine and adenine at a ratio of 1:20 or more in vivo. An oligonucleotide containing the photoproduct showed the transforming activity of as low as 3-5% of that of the corresponding unmodified oligonucleotide. This bypass absolutely required REV1 gene. The sequence analysis of the transformants has shown that the lesion was read as TT and TC at a ratio of 3:7, indicating its high mutagenic potential. FAU - Otsuka, Chie AU - Otsuka C AD - Gene Research Center, Okayama University, Tsushima, Okayama, Japan. FAU - Kobayashi, Keita AU - Kobayashi K FAU - Kawaguchi, Naho AU - Kawaguchi N FAU - Kunitomi, Nozomu AU - Kunitomi N FAU - Moriyama, Kei AU - Moriyama K FAU - Hata, Yoshihiro AU - Hata Y FAU - Iwai, Shigenori AU - Iwai S FAU - Loakes, David AU - Loakes D FAU - Noskov, Vladimir N AU - Noskov VN FAU - Pavlov, Youri AU - Pavlov Y FAU - Negishi, Kazuo AU - Negishi K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - Netherlands TA - Mutat Res JT - Mutation research JID - 0400763 RN - 0 (DNA Primers) RN - 0 (DNA, Fungal) RN - 0 (Mutagens) RN - 0 (Oligonucleotides) SB - IM MH - Base Sequence MH - *DNA Damage MH - DNA Primers MH - DNA, Fungal/*genetics MH - Mutagens/*pharmacology MH - Oligonucleotides/*pharmacology MH - Saccharomyces cerevisiae/*genetics EDAT- 2002/05/09 10:00 MHDA- 2002/07/12 10:01 CRDT- 2002/05/09 10:00 PHST- 2002/05/09 10:00 [pubmed] PHST- 2002/07/12 10:01 [medline] PHST- 2002/05/09 10:00 [entrez] AID - S0027510702000234 [pii] AID - 10.1016/s0027-5107(02)00023-4 [doi] PST - ppublish SO - Mutat Res. 2002 May 22;502(1-2):53-60. doi: 10.1016/s0027-5107(02)00023-4.